Alternatives to Cellbyte

Oncology real-world evidence platform turning patient data into AI-assisted cancer research insights.

Agentic AI platform that watches food and beverage signals across 59 markets and hands F&B teams finished, cited trend briefs.

Insight Booster automates enterprise-scale research, analysis, and report generation with agentic AI workflows.

Independent A–F carbon credit ratings and market intelligence for professional carbon buyers, developers, and investors.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data for discovery teams.

FDA-cleared AI for cancer pathology: prostate, breast, GI and pan-cancer detection on H&E slides, plus Virchow foundation models for research.

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

NExTNet pairs evidence-backed Copilot answers with Explorer's connected knowledge maps for life sciences research.

Project-based AI biopharma team that delivers decision-grade research, analysis, and computational design in 3–5 days.

A research-stage AI platform for discovering neurotherapeutics that act on neural circuits across multiple disorders.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

AI infrastructure that turns clinical data into publication-ready real-world evidence in minutes.

PicnicAI turns patient health records into clinical research data and real-world evidence.

BioStack Platforms supplies structured clinical datasets and RL environments for healthcare AI teams.

Per-plant crop intelligence platform from Alphabet's X, now acquired by Driscoll's and John Deere

Owkin's K Pro is an autonomous AI scientist agent that informs biopharma R&D, clinical trial and portfolio decisions.

Clinical-stage AI drug discovery company running a wet-and-dry lab-in-the-loop engine with 2M weekly experiments and a 50+ PB phenomics dataset

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Silico is Goodfire's interpretability agent for understanding, debugging, and controlling the internals of your AI models

Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease through partnership-led discovery.

Generative AI drug discovery suite covering target ID, molecule design, biologics engineering and clinical trial prediction.

Clay is a go-to-market data and AI research platform for teams that want to build their own enrichment, signal, and outbound workflows instead of renting a

All-in-human AI foundation models that predict brain activity and therapy response for CNS drug programs

Iktos pairs generative AI with robotic lab automation to compress small-molecule drug discovery.

AI Voice of the Customer analytics that turns unstructured customer feedback into measurable business outcomes

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Physics-based simulation plus AI for molecular discovery across drug and materials design.

Cloud-based medical imaging platform that turns MRI, CT, and PET scans into regulatory-cleared quantitative imaging biomarkers.

Tempus is an AI precision oncology platform that pairs tumor DNA/RNA sequencing with a 7M+ de-identified clinical record library for treatment and trial

AI-native biotech pairing 20+ petabytes of cellular experiments with population genetics to find causal drug targets